Briacell Therapeutics CORP. (BCTXZ) — 10-K Filings
All 10-K filings from Briacell Therapeutics CORP.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
BriaCell's Immunotherapy Shows Promise in Metastatic Breast Cancer
— Oct 16, 2025 Risk: high
BriaCell Therapeutics Corp. (BCTXZ) is a clinical-stage biotechnology company focused on novel immunotherapies for cancer. The company is advancing its Bria-IMT -
BriaCell Therapeutics Files 2024 10-K
— Oct 29, 2024 Risk: medium
BriaCell Therapeutics Corp. filed its 10-K for the fiscal year ending July 31, 2024, reporting on its financial condition and business operations. The company,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX